The drug discovery revolution is real but radically overstated, the health chatbots are a documented hazard, and the diseases that matter most remain stubbornly unsolved. At Novartis, sometime in late 2025, a team of researchers working on Huntington’s disease used generative AI to computationally design 15 million potential compounds for a type of molecule called […]
This story continues at The Next Web